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Malaria parasites retain a relict plastid (apicoplast) from a photosynthetic ancestor. The apicoplast is a
useful drug target but the speciﬁcity of compounds believed to target apicoplast fatty acid biosynthesis
has become uncertain, as this pathway is not essential in blood stages of the parasite. Herbicides that
inhibit the plastid acetyl Coenzyme A (Co-A) carboxylase of plants also kill Plasmodium falciparum
in vitro, but their mode of action remains undeﬁned. We characterised the gene for acetyl Co-A carbox-
ylase in P. falciparum. The P. falciparum acetyl-CoA carboxylase gene product is expressed in blood stage
parasites and accumulates in the apicoplast. Ablation of the gene did not render parasites insensitive to
herbicides, suggesting that these compounds are acting off-target in blood stages of P. falciparum.
 2014 TheAuthors. Published byElsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The identiﬁcation of a fatty acid biosynthesis (FASII) pathway in
the vestigial plastid (apicoplast) of the human malaria parasite
Plasmodium falciparum (Waller et al., 1998) overturned the dogma
that malaria parasites are unable to synthesise fatty acids de novo
(Holz, 1977; Vial and Ancelin, 1992). Previously, it had been pre-
sumed that parasites scavenge all their fatty acid requirements
from the host. Indeed, fatty acids are an essential media ingredient
for in vitro culture of P. falciparum (Mi-Ichi et al., 2006, 2007) and
scavenging is likely the principal source of fatty acids. What the
apicoplast FASII system contributes to the overall parasite fatty
acid budget at each stage of its life cycle is still under investigation
(Botté et al. 2013).
After their initial discovery, apicoplast FASII enzymes quickly be-
came the focus of drug discovery strategies to combatmalaria. Fatty
acid synthesis in the apicoplast utilises enzyme processes that are
markedly different from those found in humans, making fatty acid
synthesis a potentially attractive target for the development of
novel anti-malarial drugs. Whereas human FASI is a multi-activitysingle protein, in FASII systems of apicoplasts, bacteria and plant
plastids, a number of separate enzymes combine with acyl carrier
protein (ACP) to form a complex able to extend acyl chains itera-
tively by two carbon units (Smith, 1994). Various inhibitors of bac-
terial or plant plastid FASII enzymes (thiolactomycin, triclosan and
the aryloxyphenoxypropionate and cyclohexanedione herbicides)
were shown to kill malaria parasites, and the presumedmode of ac-
tion was perturbation of apicoplast fatty acid biosynthesis (Waller
et al., 1998, 2003; Zuther et al., 1999; Surolia and Surolia, 2001;
Jelenska et al., 2002; Ramya et al., 2007).
Both FASI and FASII are fed by acetyl Coenzyme A (Co-A) carbox-
ylase (ACC), which converts acetyl-CoA and carbonate into
malonyl-CoA, the substrate used in acyl chain extension. The ACC
for FASI is typically cytosolic in eukaryotes, whereas ACC for FASII
is located in the plastids of plants and algae. Malonyl-CoA produc-
tion by ACC is the ﬁrst committed step in fatty acid synthesis; ACC
activity controls the ﬂux of precursors into the fatty acid synthesis
pathway, thereby regulating the rate of fatty acid synthesis (Kim,
1997). The P. falciparum genome contains a single copy of ACC
(PlasmoDB Gene ID: PF3D7_1469600). The gene encodes a large,
multifunctional protein with a biotin carboxylase domain, a biotin
carboxy domain and a carboxy transferase domain (Goodman and
McFadden, 2007). The multifunctional apicoplast ACC is reminis-
cent of the equivalent enzymes from the plastids of grasses and
algae such as diatoms, which also have a nucleus-encoded multi-
functional ACC.
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of dicotyledonous plants, is the target of two classes of grass-spe-
ciﬁc herbicides: the aryloxyphenoxypropionates (fops) and the
cyclohexanediones (dims). These herbicides are widely used in
agriculture to control grassy weeds, and there is a signiﬁcant body
of knowledge regarding their enzymology, structural biology and
toxicology (Preston and Powles 2002; Yu et al. 2013). Initial trials
using one fop and one dim showed inhibition of P. falciparum
in vitro growth, but the concentrations were orders of magnitude
greater than normally used against grasses (Waller et al., 2003;
Ramya et al., 2007). We followed up this initial study with a range
of compounds potent against grass ACC to test whether better
activity against P. falciparum could be obtained. Although more po-
tent compounds with low micromolar half maximal inhibitory
concentrations (IC50) values against P. falciparum were produced,
the structure activity relationships were not consistent with inhi-
bition of parasite ACC (Louie et al., 2010). It appeared possible that
these herbicides, although parasiticidal, are off target (Botté et al.,
2012).
If drugs are to be targeted against a particular parasite enzyme,
ideally the activity of that enzyme should be essential during the
particular parasite stage being pursued. Themalaria parasite life cy-
cle shifts frommosquitoes to vertebrate by mosquito bite. Parasites
injected into mammals by the bite, travel to the liver and initially
establish themselves there beforemultiplying and then shifting into
red blood cells. Gene ablation studies in P. falciparum and two spe-
cies of rodent malaria (Plasmodium yoelii and Plasmodium berghei)
to knock down different apicoplast fatty acid biosynthesis (fab)
genes have demonstrated that apicoplast FASII is not essential for
growth of parasites in the blood stage (Yu et al., 2008; Vaughan
et al., 2009; Pei et al., 2010). Similarly, deletion of either the E1alpha
or E3 subunits of the apicoplast pyruvate dehydrogenase complex
(PDH) that generates acetyl-CoA from pyruvate in P. yoelii, yield via-
ble blood stage parasites. These gene ablation studies show that
FASII is dispensable in blood stages of human and rodent malaria.
FASII is also dispensable in rodent insect stages, but vital for liverFig. 1. Plasmodium falciparum acetyl CoA carboxylase is targeted to the apicoplast. (A) Sin
falciparum acetyl CoA carboxylase. (B) Western blot probed with anti-haemagluttinin
immunoﬂuorescence assay of P. falciparum acetyl CoA carboxylase-haemagluttinin tran
apicoplast (green, P. falciparum acetyl CoA carboxylase-haemagluttinin labelled with ant
blue, DNA stained with Hoechst 33342). Bar = 1 lm.stage in P. yoelli (Vaughan et al., 2009) and important, but not abso-
lutely essential, for liver stage in P. berghei (Yu et al., 2008). Surpris-
ingly, a recent report demonstrates that FASII mutants in P.
falciparum are viable in blood stages but are required for parasite
development in themosquitomidgut (van Schaijk et al., 2013), sug-
gesting differences in the metabolic requirements of rodent and
human malaria parasites during the insect stage.
To investigate the essentiality of ACC, which feeds carbons to
FASII, we deleted the gene in blood stage P. falciparum parasites
and successfully recovered viable parasites. We then tested herbi-
cides against these ACC minus parasites to determine whether ACC
is the target of these inhibitors.2. Materials and methods
2.1. Creation of allelic replacement and gene disruption constructs
Allelic replacement constructs designed to introduce an haema-
gluttinin (HA) tag were created using the MultiSite Gateway sys-
tem™ (Invitrogen, Australia), as previously described (van Dooren
et al., 2005). A 1,055 bp portion of the 30 end of the P. falciparum
ACC (PfACC) gene (PlasmoDB gene ID: PF3D7_1469600) was ampli-
ﬁed from parasite line 3D7 genomic DNA using the primers D137
and D138, adding the AttB4 and AttB1 sites to the 50 and 30 end of
the PCR product, respectively (Supplementary Table S1). The
PfACC30 product was TA cloned into a pGEM-T vector (Promega,
Australia) and sequenced. PfACC30HA was linearised with ClaI
restriction enzyme digestion and recombined into pDONR P4-P1
according to the manufacturer’s instructions, creating PfACC30-P4P1.
The ﬁnal construct, PfACC30HA (Fig. 1A), was created by recombining
PfACC30-P4P1with a 3xHA tag carrying a stop codon in pDONR221, a
ﬁller construct (3xHA tag in pDONRP2P3), and a human dihydrofolate
reductase (hDHFR) selection cassette (Fidock and Wellems, 1997) in
pCHD3/4 via the Gateway multisite LR™ reaction (Invitrogen,
Australia).gle crossover strategy for adding an haemagluttinin tag to the endogenous copy of P.
antibody showing a single haemagluttinin speciﬁc band at >220 kDa. (C) Indirect
sgenic parasites showing localisation of P. falciparum acetyl CoA carboxylase in the
i-haemagluttinin antibody; red, apicoplast labelled with anti-Pf acyl carrier protein;
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Fig. 2. Plasmodium falciparum acetyl CoA carboxylase is not essential in blood stages. (A) Diagram of two independent double crossover constructs used to knockout P.
falciparum acetyl CoA carboxylase in parasite lines D10 (PfACCKO1) and 3D7 (PfACCKO2) showing location of enzymes and probes (black bar) used in Southern blot analysis.
Predicted restrictions fragment sizes are listed in Supplementary Table S3. hDHFR, human dihydrofolate reductase. (B) Southern blot analysis conﬁrms insertion of knockout
construct into P. falciparum acetyl CoA carboxylase. WT, wild type. (C) Chart of parasite growth rate showing no signiﬁcant difference in growth of knockout lines versus
parental (wild type) strain (D10, P = 0.398; 3D7, P = 0.574, n = 3).
Fig. 3. Plasmodium falciparum acetyl CoA carboxylase is not the target of ACC
inhibiting herbicide, butroxydim. Dose–response curves for inhibition of P. falcipa-
rum acetyl CoA carboxylase knockout and D10 and 3D7 parental strains by the grass
ACC inhibiting herbicide, butroxydim (n = 3).
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plasmid pCC1 (Maier et al., 2006). The 50 and 30 ﬂanks of PfACC
(Supplementary Table S2) were PCR ampliﬁed from 3D7 genomic
DNA using primers listed in Supplementary Table S1. The products
were Topo-TA cloned into plasmid pCR2.1 (Invitrogen) and
sequenced. The resulting ﬂanks were cloned into pCC-1 to create
knockout (KO) mutants PfACCKO1 and PfACCKO2 (Fig. 2A).
2.2. Parasite culture and transfection
Parasites were grown as previously described (Trager and
Jensen, 1976). The allelic replacement construct was transfected
into the D10 parasite line and the gene disruption constructs were
transfected into both D10 and 3D7 parasites. All transfections were
performed as previously described (Crabb and Cowman, 1996;
Tonkin et al., 2004) and yielded drug resistant parasites within
20–30 days. The ACC30HA lines were subjected to three cycles of
alternating drug selection to enrich for lines carrying the inte-
grated tag. Lines carrying the KO constructs were negatively
selected with 1 lM 5-Fluorocytosine to eliminate episomal copies
(Maier et al., 2006).
2.3. Southern and Western blotting
Integration of gene disruption constructs was conﬁrmed by
Southern blot analysis performed as previously described (Crabbet al., 1997; Kalanon et al., 2009). Genomic DNA puriﬁed by phe-
nol–chloroform extraction of saponin lysed parasites was digested
and probed as shown in Fig. 2A. The sizes of the expected frag-
ments are detailed in Supplementary Table S3. DNA probes were
Table 1
Comparison of acetyl CoA carboxylase inhibitor effects on Plasmodium falciparum acetyl CoA carboxylase knockout parasites.
Inhibitor Strain IC50 (lM) P value
Butroxydim D10 17.5 0.45
D10 KO1 21.9
3D7 16.8 0.69
3D7 KO2 19.4
Dimeric cyclohexane-1,3-dione oxime 11 3D7 3.0 0.86
3D7 KO2 4.4
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using the Prime-a-Gene system (Promega). Western blots were
performed as previously described (Mullin et al., 2006). Mouse
anti-HA primary antibody (Roche, Australia) was diluted 1/500,
and anti-mouse horseradish peroxidase (HRP) secondary antibody
(Thermo Fisher Scientiﬁc, Australia) was diluted 1/5,000.
2.4. Immunoﬂuorescence assays and microscopy
Immunoﬂuorescence assays were performed as previously de-
scribed (Tonkin et al., 2004). Rat anti-HA primary antibody (Roche)
was diluted 1/200. Goat anti-rat antibody conjugated to Alexaﬂuor
488 (Molecular Probes, Australia) was diluted 1/1,000. Rabbit anti-
PfACP antibody (Waller et al., 2000) was diluted 1/1,000, as was
anti-rabbit antibody conjugated to Alexaﬂuor 546 (Molecular
Probes). Nuclei were stained using Hoechst 33258. Images were
collected with a Leica SP2 confocal microscope, adjusted for bright-
ness and contrast, merged and assembled into panels using Adobe
Photoshop.
2.5. Parasite growth assays and drug trials
Analysis of parasite growth rates was performed using Giemsa
stained parasites prepared as previously described (Goodman
et al., 2007). Tightly synchronised parasites were started at low
(0.1–0.2%) parasitemia and grown for 96 h. Total parasitemia was
assessed at 24 h intervals. Statistical comparisons of growth rates
were carried out using Excel software (Microsoft, USA).
The ACC inhibitors butroxydim and dimeric cyclohexane-1,3-
diome oxime 11 (Louie et al., 2010) were dissolved in DMSO at
1,000 the maximum concentration and diluted with growth med-
ia to working concentrations. Parasite growth rates were assessed
using a modiﬁed version of the SYBRgreen assay (Smilkstein et al.,
2004; Goodman et al., 2007). Calculation of IC50 values and statis-
tical comparison between strains (Mann–Whitney test) were
carried out using GraphPad Prism Software.
3. Results and discussion
3.1. PfACC localises to the apicoplast
The PfACC protein was tagged at the C-terminus with HA pep-
tide by allelic replacement via a single crossover to modify the 30
end of the gene. Integration was conﬁrmed by Western blotting
of parasite proteins with anti-HA sera, which identiﬁed a band
with molecular mass consistent with the predicted mass of
395 kDa (Fig 1A). Immunoﬂuorescence assays using anti-HA sera
on early trophozoite stage parasites expressing HA-tagged PfACClabelled a small structure in the parasites that is also positive for
the apicoplast marker ACP (Fig 1B). Negative control immunoﬂuo-
rescence assays on wild type D10 parasites did not label the api-
coplast with anti-HA sera (data not shown). The PfACC gene thus
encodes an apicoplast-localised protein of approximately the ex-
pected mass in blood stages, conﬁrming a prediction of apicoplast
targeting based on the presence of a bipartite N-terminal leader
(Ralph et al., 2004). This also conﬁrms that PfACC is expressed at
detectable levels during the blood stage, suggesting possible
activity.
3.2. Deletion of PfACC yields viable blood stage parasites
Several genes of the apicoplast FASII pathway are dispensable in
the blood stages of Plasmodium spp. infections (Yu et al., 2008;
Vaughan et al., 2009; Pei et al., 2010), suggesting that de novo fatty
acid synthesis is not essential for successful erythrocytic infection.
The only predicted role for PfACC is providing precursors for FASII.
To test whether PfACC is also dispensable in blood stages we con-
structed two independent deletions of PfACC in both 3D7 and D10
parasite strains. In each line, integration of the construct deleted
more than 6 kb of the PfACC gene (Fig 2A). Following negative
selection with 5-FC to eliminate episomal copies of the construct,
Southern blotting conﬁrmed the integration of the gene deletion
construct and the clonal nature of the parasite line (Fig. 2B).
Growth rates based on total parasitemia were not observably dif-
ferent between the parental and the knockout strains (Fig 2C) con-
ﬁrming that in the red blood cell stages, PfACC is dispensable. This
suggests that this protein does not have critical roles in the blood
stage beyond the provision of malonyl-CoA for apicoplast localised
fatty acid synthesis.
The role of ACC beyond the asexual stage in red blood cells re-
mains unexplored. In rodent parasites there is a common pheno-
type seen in parasites lacking either the PDH (Pei et al., 2010),
which provides substrates for ACC, or the downstream FASII genes
(Yu et al., 2008; Vaughan et al., 2009). Therefore, it would be sur-
prising if ACC KOs yield a different phenotype and this would sug-
gest that ACC has a function beyond fatty apicoplast fatty acid
synthesis in the mosquito stage. In P. falciparum it would be
expected that, similar to the FASII KOs (van Schaijk et al., 2013),
ACC KO parasites would fail to complete the mosquito stage. Again,
any novel phenotype in the stages prior to sporozoite development
would suggest alternative functions for ACC.
3.3. Herbicide trials with ACC minus parasites
Wild type (D10 and 3D7) and corresponding PfACC minus
parasite lines (D10 KO1 and 3D7 KO2) were exposed to the ACC
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was no observable difference in the growth response of the knock-
out parasites when compared with the parental strains. The
observed IC50 values of the deletion parasites (Table 1) were in
agreement with those reported previously (Louie et al., 2010)
and there was no signiﬁcant difference in the IC50 values found be-
tween the parasite lines carrying the gene deletion and wild type
strains for either compound. Similar results were found for when
the inhibitor dimeric cyclohexane-1,3-dione oxime 11 (Louie
et al., 2010) was tested against the 3D7 and 3D7 KO2 parasite lines
(Table 1) with no signiﬁcant differences between the IC50 values for
the two lines. We conclude that ACC is not the target of these com-
pounds and that their parasiticidal activity is off target.
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